Burden of Severe Disease Associated With Influenza, SARS‐CoV‐2 and RSV in Spain During the 2024–2025 Winter Season
Influenza and Other Respiratory Viruses · 2025-11 · 19 (11)
DOI: 10.1111/irv.70190 ↗Kurz gefasst
Fachartikel in der Zeitschrift Influenza and Other Respiratory Viruses, online erschienen am 18.11.2025. Verfasst von Daniel Aguilar Figueroa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Preventive Medicine Department, San Eloy Hospital, Barakaldo-Sestao Health Integrated Organization, Barakaldo, Spain. Hauptthemen laut MEDLINE: COVID-19, Influenza, Human, Respiratory Syncytial Virus Infections. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
We estimated the burden of influenza, SARS‐CoV‐2 and RSV from patients hospitalized with acute respiratory infection systematically tested between weeks 40/2024 and 20/2025 in Spain. The hospitalization rate per 100,000 was highest for influenza [67.5 (95% Confidence Interval: 52.5–87.3)] followed by RSV [46.6 (35.4–62.2)] and SARS‐CoV‐2 [15.8 (10.2–24.6)]. Hospitalization rates peaked in ≥ 60‐year‐olds and < 5‐year‐olds, ICU admissions in < 1‐year‐olds and deaths in ≥ 80‐year‐olds. Hospitalization for SARS‐CoV‐2 at 80–85 years was comparable to influenza at 60–65 years, potentially signaling the appropriateness of increasing the COVID‐19 vaccination age cut‐off. RSV prevention appeared a priority in < 5‐year‐olds but substantial preventive potential was identified in the elderly.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Preventive Medicine Department, San Eloy Hospital, Barakaldo-Sestao Health Integrated Organization, Barakaldo, Spain.
- National Centre of Epidemiology, Carlos III Health Institute (CNE-ISCIII), Madrid, Spain.
- Biomedical Research Network on Epidemiology and Public Health (CIBERESP), Madrid, Spain.
- Biomedical Research Network on Infectious Diseases (CIBERINFEC), Madrid, Spain.
Zitieren
APA
Aguilar Figueroa, D., Pérez-Gimeno, G., Núñez, O., Monge, S., & SiVIRA Surveillance and Vaccine Effectiveness Working Group (2025). Burden of Severe Disease Associated With Influenza, SARS‐CoV‐2 and RSV in Spain During the 2024–2025 Winter Season. Influenza and Other Respiratory Viruses, 19(11). https://doi.org/10.1111/irv.70190
Vancouver
Aguilar Figueroa D, Pérez-Gimeno G, Núñez O, Monge S, SiVIRA Surveillance and Vaccine Effectiveness Working Group. Burden of Severe Disease Associated With Influenza, SARS‐CoV‐2 and RSV in Spain During the 2024–2025 Winter Season. Influenza and Other Respiratory Viruses. 2025;19(11). doi:10.1111/irv.70190
BibTeX
@article{AguilarFigueroa2025,
author = {Aguilar Figueroa, Daniel and Pérez-Gimeno, Gloria and Núñez, Olivier and Monge, Susana and SiVIRA Surveillance and Vaccine Effectiveness Working Group, SiVIRA Surveillance and Vaccine Effectiveness Working Group},
title = {Burden of Severe Disease Associated With Influenza, SARS‐CoV‐2 and RSV in Spain During the 2024–2025 Winter Season},
journal = {Influenza and Other Respiratory Viruses},
year = {2025},
volume = {19},
number = {11},
doi = {10.1111/irv.70190}
}
EUVIMED